Bristol-Myers Squibb

Personalizing Veterans' Lung Cancer Screening and Diagnosis

CollaboratorNo phaseEnrolling by invitation1,400 people24 Sept 2026clinicaltrials.gov

A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)

CollaboratorPhase 2Recruiting42 people15 Jul 2026clinicaltrials.gov

NCT07680790

Phase 3Not yet recruiting850 people2 Jul 2026clinicaltrials.gov

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 2Recruiting160 people2 Jul 2026clinicaltrials.gov

NCT07629999

Phase 1Recruiting136 people5 Jun 2026clinicaltrials.gov

NCT07624513

CollaboratorPhase 3Not yet recruiting720 people3 Jun 2026clinicaltrials.gov

NCT07608731

CollaboratorPhase 1Not yet recruiting18 people27 May 2026clinicaltrials.gov

NCT07223671

Phase 1Completed30 people3 Nov 2025clinicaltrials.gov

NCT07212062

CollaboratorPhase 2Not yet recruiting60 people8 Oct 2025clinicaltrials.gov

NCT07106762

Phase 2/3Recruiting470 people6 Aug 2025clinicaltrials.gov

NCT07100080

Phase 2/3Recruiting500 people3 Aug 2025clinicaltrials.gov

NCT07063745

Phase 2/3Recruiting590 people14 Jul 2025clinicaltrials.gov

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Phase 3Recruiting586 people16 May 2025clinicaltrials.gov

NCT06946797

Phase 2Active, not recruiting76 people27 Apr 2025clinicaltrials.gov

NCT06929273

Phase 3Recruiting450 people16 Apr 2025clinicaltrials.gov

NCT06561386

Phase 3Recruiting1,000 people20 Aug 2024clinicaltrials.gov

NCT06518551

CollaboratorPhase 1/2Recruiting49 people24 Jul 2024clinicaltrials.gov

NCT06284564

CollaboratorPhase 2Active, not recruiting10 people29 Feb 2024clinicaltrials.gov

NCT06216158

CollaboratorPhase 3Active, not recruiting411 people22 Jan 2024clinicaltrials.gov

NCT06094296

Phase 2Terminated1 person23 Oct 2023clinicaltrials.gov